Medovate Announces Exclusive Agreement with U.S. Based Mercury Medical to Distribute SAFIRA

Mercury Medical has positioned itself as a US leader in providing technological advances for clinicians in both airway solutions and anesthesia, a philosophy that aligns with Medovate and SAFIRA™.

Medovate Signs Exclusive Agreement with Vygon to Distribute SAFIRA

SAFIRA, developed in collaboration with UK National Health Service (NHS) clinicians, transforms the technique of Peripheral Nerve Blockade into a one-person procedure, giving the anesthetist full control of the injection at all times.

SAFIRA® Anaesthesia Device Receives European CE Regulatory Approval

SAFIRA ® is a revolutionary new technology that transforms regional anesthesia into a one-person procedure, putting control in the hands of the anesthetist.